Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis
- 1 December 1995
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 33 (6) , 973-978
- https://doi.org/10.1016/0190-9622(95)90289-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Decreased Collagenase Expression in Cultured Systemic Sclerosis FibroblastsJournal of Investigative Dermatology, 1994
- Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosisHepatology, 1994
- Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinomaClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases An application for rheumatoid arthritis serum and plasmaJournal of Immunological Methods, 1990
- SERUM TYPE III PROCOLLAGEN PEPTIDE CONCENTRATIONS IN SYSTEMIC SCLEROSIS AND RAYNAUD'S PHENOMENON: RELATIONSHIP TO DISEASE ACTIVITY AND DURATIONRheumatology, 1989
- Type III Collagen Aminopropeptide Levels in Serum of Patients With Progressive Systemic SclerodermaJournal of Investigative Dermatology, 1986
- Variability in Collagen and Fibronectin Synthesis by Scleroderma Fibroblasts in Primary CultureJournal of Investigative Dermatology, 1981
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- SclerodermaJournal of Clinical Investigation, 1979
- Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro A POSSIBLE DEFECT IN THE REGULATION OR ACTIVATION OF THE SCLERODERMA FIBROBLASTJournal of Clinical Investigation, 1974